Citigroup Inc Baxter International Inc Call Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$32.85 - $40.26 $1.91 Million - $2.34 Million	-58,100 Reduced 23.47%	189,500 $7.2 Million
Q2 2024 Aug 12, 2024	BUY	$32.87 - $43.55 $6.16 Million - $8.16 Million	187,300 Added 310.61%	247,600 $8.28 Million
Q1 2024 May 10, 2024	SELL	$37.88 - $43.77 $556,836 - $643,419	-14,700 Reduced 19.6%	60,300 $2.58 Million
Q3 2023 Nov 09, 2023	BUY	$37.32 - $49.29 $2.8 Million - $3.7 Million	75,000 New	75,000 $2.83 Million
Q1 2023 May 11, 2023	SELL	$37.58 - $52.57 $1.6 Million - $2.24 Million	-42,600 Reduced 26.63%	117,400 $4.76 Million
Q3 2022 Nov 10, 2022	BUY	$53.86 - $66.8 $8.62 Million - $10.7 Million	160,000 New	160,000 $8.62 Million

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.